2125. Activity of Novel β-Lactam/β-Lactamase Inhibitor Combinations against Serine-Carbapenemase producing Carbapenem-Resistant Pseudomonas aeruginosa

BACKGROUND: Antimicrobial resistance in Pseudomonas aeruginosa is complex and multifaceted. While the novel β-lactamase inhibitors (BLI), avibactam, relebactam, and vaborbactam inhibit serine-based β-lactamases, the comparative potency of the novel β-lactam (BL) /BLI combinations against serine-carb...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Young, Gill, Christian M, Nicolau, David P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679175/
http://dx.doi.org/10.1093/ofid/ofad500.1748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679175/
http://dx.doi.org/10.1093/ofid/ofad500.1748

Ejemplares similares